EVEREST: Attempting the Summit with Adjuvant Everolimus To Treat High-risk Renal Cell Carcinoma After Surgery

Eur Urol. 2024 Sep;86(3):265-267. doi: 10.1016/j.eururo.2024.05.024. Epub 2024 Jun 12.

¹ Department of Urology and Transplantation Surgery and Eva Mayr-Stihl Cancer Center, Klinikum Stuttgart, Katharinenhospital, Stuttgart, Germany. Electronic address: [email protected].
² The Royal Free London NHS Foundation Trust, London, UK; UCL Division of Surgery and Interventional Science, University College London, London, UK; Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

No abstract available

Publication types